<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563200/" ref="ordinalpos=2437&amp;ncbi_uid=4616855&amp;link_uid=PMC3563200" image-link="/pmc/articles/PMC3563200/figure/fig05/" class="imagepopup">Figure 5.  From: Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">IDO1 stimulates COX-2, MMP-9 expression in ESCs through activation of JNK signaling pathway. IDO1 in normal ESCs was overexpressed or blockaded by plasmid transfection, and treated with or without JNK inhibitor (SP600125, 20μM). The expression of invasion-related proteins MMP-2 (A), MMP-9 (B), TIMP-1 (C) and COX-2 (D) were determined by in-cell Western. Data were shown as the mean ± SD calculus of 8 different experiments; *P&lt;.05 vs. vector control transfected ESCs without SP600125; **P&lt;.01 vs. vector control transfected ESCs without SP600125; #P&lt;.05, IDO1-overexpressing ESCs with SP600125 vs. IDO1-overexpressing ESCs without SP600125; ##P&lt;.01, IDO1-overexpressing ESCs with SP600125 vs. IDO1-overexpressing ESCs without SP600125.</div></div>